Navigation Links
ThermoGenesis Announces National Institute of Health Grant
Date:6/9/2009

COMPANY'S FIRST-EVER NIH GRANT WILL BE USED TO DEVELOP CELL DELIVERY TECHNOLOGIES FOR REGENERATIVE MEDICINE APPLICATIONS

RANCHO CORDOVA, Calif., June 9 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products for processing and storing adult stem cells, said today it has received a grant from the National Institute of Health (NIH) to study and develop biomaterials that can be used to deploy placental stem cells in bone repair and regenerative medicine applications.

The approximate $500,000, two-year grant, the Company's first-ever funding from the NIH, is a Phase I Small Business Innovation Research grant from the National Institute on Aging. The study will be conducted at the Company's stem cell research laboratory and through a collaboration with the University of California, Davis. The Company can apply for a Phase II grant once the work under this initial contract is completed.

"Being awarded this grant is an important milestone for the Company. These funds enable us to conduct exploratory research in animal models to identify the best methods of combining stem cells with biomaterials," noted Mel Engle, Chief Executive Officer of ThermoGenesis. "We will be using stem cell concentrates prepared by our AXP(TM) AutoXpress (AXP(TM)), MarrowXpress(TM) (MXP) and Res-Q(TM) cell separation technologies as well as cells derived from the placenta. The goal of this research is to provide an integrated cell processing and delivery system designed to achieve an optimal therapeutic effect in orthopedic applications, such as bone repair and generation." Engle said the Company's research is based upon the growing body of evidence which shows that the efficacy of stem cells for tissue regeneration and repair can be enhanced if the cells are presented to the body wi
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014 The steady decline ... spreading to previously rep-friendly specialties, according to the ... marketing consulting firm ZS Associates.      ... U.S. pharmaceutical sales teams. The report examines how ... with the pharmaceutical sales reps who visit their ...
(Date:7/22/2014)... -- BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: ... appointed Charles J. (Chuck) Bramlage and Dr. ... Board.  Mr. Bramlage is a veteran ... and other commercial functions.  He is currently the Chief ... company that was recently acquired by AstraZeneca and is ...
(Date:7/22/2014)... , July 22, 2014  UL (Underwriters ... that the U.S. Food and Drug Administration (FDA) ... consensus standards for medical devices incorporating lithium or ... - Standard for Household and Commercial Batteries, and ... Consensus standards are standards recognized ...
Breaking Medicine Technology:Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 2Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 3Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 4Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 5BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 2BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 3BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 4BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 5BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 6BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 7Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Devices 2
... China Medicine Corporation (OTC Bulletin Board: CHME ... of Western pharmaceuticals, traditional Chinese medicines ("TCM"), and other ... announced that it has filed with the United States ... Form 8-K to disclose that its previously issued financial ...
... THOUSAND OAKS, Calif., March 23, 2011 Amgen ... data that showed postmenopausal women with osteoporosis had ... (denosumab) treatment than during alendronate treatment, an oral ... Adherence to treatment, which includes both compliance ...
Cached Medicine Technology:China Medicine Corporation Files Extension for Fiscal 2010 Form 10-K Filing 2China Medicine Corporation Files Extension for Fiscal 2010 Form 10-K Filing 3Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 2Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 3Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 4Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 5Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 6Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 7Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 8Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 9Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 10Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 11
(Date:7/22/2014)... Roanoke, VA (PRWEB) July 22, 2014 ... as a young child. While most kids outgrow ... Tonelson did not. He is among the three million ... can range from mild to severe. Throughout his youth, ... attending in-school speech sessions and visits with private speech-and-language ...
(Date:7/22/2014)... 2014 BESLER Consulting, a leading ... for hospitals, is pleased to offer a complimentary ... to assist hospitals with analyzing their 2015 QualityNet ... on July 21 allow hospitals to validate their ... However, the data contained in these reports can ...
(Date:7/22/2014)... 2014 Kirby Lester, LLC, the leading ... includes streamlined functionality to perform a trackable double-count for ... Since a double-count of controlled medications is required, the ... quickly perform a second count of any tablet or ... of the second count up to 10 years. This ...
(Date:7/22/2014)... Hill, South Carolina (PRWEB) July 22, 2014 ... weight loss solution managed to lose 20 pounds. Unfortunately, the ... shaky and nauseated for the duration of her time using ... ‘manic’. One woman experienced heart flutters and insomnia as a ... woman experienced a heart attack at the age of 37 ...
(Date:7/22/2014)... 22, 2014 Ronald S. Weaver, ... Inglewood, Calif., today announced a heart transplant patient with ... Counterpulsation (EECP) therapy at Global Cardio Care Centers and ... , The patient, a 55-year-old Hispanic male, also ... Life Program, a nutrition and exercise lifestyle program in ...
Breaking Medicine News(10 mins):Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 2Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 3Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 4Health News:Complimentary Re-admissions Analytics Tool Available From BESLER Consulting 2Health News:Kirby Lester KL1Plus Pharmacy Automation Perfect for Double-Counting & Tracking Prescriptions from Any Pharmacy Robot 2Health News:SlimPlate System Urge Women to Shun Controversial Weight Loss Pills for Healthier Methods Like Portion Control 2Health News:Ronald S. Weaver, MD, Owner of Global Cardio Care Centers, Announces EECP Treatment Success for Cardiomyopathy Patient Who Needed Heart Transplant 2Health News:Ronald S. Weaver, MD, Owner of Global Cardio Care Centers, Announces EECP Treatment Success for Cardiomyopathy Patient Who Needed Heart Transplant 3
... ... professionals are turning to BurrellesLuce for valuable advice on making optimal use of Twitter and ... ... public relations practice, many PR professionals are turning to BurrellesLuce for valuable advice ...
... LINO LAKES, Minn., Aug. 26 Despite ... construction firms have been recognized by Minnesota Laborers-Employers Cooperation and ... 2008. , , Begun in 2007, the ... performance and proactive approach of Skilled Construction Union Laborers and ...
... , , WASHINGTON, Aug. ... who was a champion for vulnerable people throughout his life and a ... the midst of America,s great discussion of health care reform, Kennedy was ... We hope that Congress will honor his memory with the completion of ...
... arsenic from the body, according to a new study that ... the potentially toxic substance. The study found that some people ... the diet. Others store arsenic in their bodies, where it ... application of new methods for studying arsenic, is scheduled for ...
... , , WILMINGTON, ... comparative effectiveness study performed by HealthCore, Inc. in its August ... better clinical outcomes with oral controllers than inhaled corticosteroids. , ... requested the comparative effectiveness study to help ensure that its ...
... , JERICHO, N.Y., Aug. 26 Optimum ... New York metropolitan area businesses, today announced that Medical ... in Long Island, has selected Optimum Lightpath as its ... Optimum Lightpath,s 100% fiber Ethernet connection, Medical Arts Radiology ...
Cached Medicine News:Health News:PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 2Health News:PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 3Health News:Twenty-Two Regional Construction Firms Recognized for Their Commitment to Worker Safety 2Health News:Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than Inhaled Products 2Health News:Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than Inhaled Products 3Health News:Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than Inhaled Products 4Health News:Medical Arts Radiology Chooses Optimum Lightpath to Speed Anytime, Anywhere Access to Patient Data and Communications 2Health News:Medical Arts Radiology Chooses Optimum Lightpath to Speed Anytime, Anywhere Access to Patient Data and Communications 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: